Business Wire
-
Augurex Announces UKCA Authorization For SPINEstat, Expanding Access To A First-In-Class Diagnostic Blood Test For Axial Spondyloarthritis To Great Britain
4/23/2025
Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that SPINEstat has received UK Conformity Assessed (UKCA) marking by the Medicines and Healthcare products Regulatory Agency (MHRA), authorizing the blood test for clinical use and listing it as an in vitro diagnostic (IVD) in Great Britain.
-
Augurex Secures Health Canada Approval For SPINEstat, A First-in-Class Diagnostic Blood Test For Axial Spondyloarthritis
4/16/2025
Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axial spondyloarthritis (axSpA), as a Class II medical device.
-
Nanospeed Diagnostics Receives Health Canada Approval For Test4D Test
4/15/2025
NanoSpeed Diagnostics Inc. (“NanoSpeed”) is pleased to announce that Health Canada has approved Test4D Serum which is indicated to be used to detect Vitamin D in blood serum.
-
QIAGEN Advancing Plans To Launch Three New Sample Preparation Instruments By 2026 To Improve Lab Automation
4/15/2025
QIAGEN Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its portfolio for automated sample preparation.
-
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test For Parkinson's Disease Developed
4/14/2025
ATED Therapeutics Ltd. announced a new diagnostic test for Parkinson’s Disease, developed at Hebrew University in Jerusalem, Israel.
-
Bruker Complements Fast, Cost-Effective IR Biotyper Hospital Hygiene Testing And HAI Tracing With NGS Reflex Testing
4/11/2025
At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of its microbiology solutions into Next-Generation Sequencing (NGS) applications, with new, research-use only NGS-based solutions in epidemiology and hospital acquired infection (HAI) tracing.
-
Scientist.com Launches Clinical Labs Navigator To Expand Clinical Sourcing Capabilities
4/8/2025
Scientist.com, the leading R&D procurement orchestration platform for the life sciences, today announced the launch of Clinical Labs Navigator, a groundbreaking new tool that redefines how clinical trial services are sourced, managed, and executed.
-
hc1 Unveils Innovative Operational Excellence Healthcare Solutions
4/8/2025
hc1 introduced today its suite of Operational Excellence solutions, setting a new standard for laboratory efficiency and performance.
-
LabTAG And eLabNext Launch New Add-On For DYMO LabelWriter 5-Series For Seamless Laboratory Labeling
4/3/2025
GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its Dymo LabelWriter 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab Platform (DLP), an intuitive and flexible system for collecting, managing, and analyzing laboratory information.
-
Revvity Secures FDA Approval For Improved Automated Latent Tuberculosis Test
4/2/2025
Revvity, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT.TB test.